BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alharbi M, Lai A, Sharma S, Kalita-de Croft P, Godbole N, Campos A, Guanzon D, Salas-Burgos A, Carrion F, Zuñiga FA, Perrin L, He Y, Pejovic T, Winters C, Morgan T, Hooper JD, Rice GE, Salomon C. Extracellular Vesicle Transmission of Chemoresistance to Ovarian Cancer Cells Is Associated with Hypoxia-Induced Expression of Glycolytic Pathway Proteins, and Prediction of Epithelial Ovarian Cancer Disease Recurrence. Cancers (Basel) 2021;13:3388. [PMID: 34298602 DOI: 10.3390/cancers13143388] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Rickard BP, Conrad C, Sorrin AJ, Ruhi MK, Reader JC, Huang SA, Franco W, Scarcelli G, Polacheck WJ, Roque DM, Del Carmen MG, Huang HC, Demirci U, Rizvi I. Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response. Cancers (Basel) 2021;13:4318. [PMID: 34503128 DOI: 10.3390/cancers13174318] [Reference Citation Analysis]
2 Pereira M, Matuszewska K, Jamieson C, Petrik J. Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer. Front Endocrinol (Lausanne) 2021;12:772349. [PMID: 34867818 DOI: 10.3389/fendo.2021.772349] [Reference Citation Analysis]
3 Croft PK, Sharma S, Godbole N, Rice GE, Salomon C. Ovarian-Cancer-Associated Extracellular Vesicles: Microenvironmental Regulation and Potential Clinical Applications. Cells 2021;10:2272. [PMID: 34571921 DOI: 10.3390/cells10092272] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Liu M, Zhou X, Tang J. Non-Coding RNAs Delivery by Small Extracellular Vesicles and Their Applications in Ovarian Cancer. Front Bioeng Biotechnol 2022;10:876151. [DOI: 10.3389/fbioe.2022.876151] [Reference Citation Analysis]